Avadel Pharmaceuticals gets grant for patent granted for modified release formulation of gamma-hydroxybutyrate
Discover Avadel Pharmaceuticals' innovative patent for modified release formulations of gamma-hydroxybutyrate, enhancing dissolution and pharmacokinetic properties. Learn about the unique composition designed for oral administration.
What's Your Reaction?